simendan has been researched along with isoflurane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autschbach, R; Bernhagen, J; Bleilevens, C; Goetzenich, A; Hatam, N; Moza, A; Preuss, S; Roehl, AB; Stoppe, C | 1 |
| Akyol, O; Demirgan, S; Erkalp, K; Pekmez, M; Selcan, A; Şengelen, A; Sevdi, MS; Temel, Z; Ulaş, O | 1 |
2 other study(ies) available for simendan and isoflurane
| Article | Year |
|---|---|
The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Hydrazones; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflurane; Metoprolol; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Pyridazines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Simendan; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Xenon | 2014 |
Intranasal levosimendan prevents cognitive dysfunction and apoptotic response induced by repeated isoflurane exposure in newborn rats.
Topics: Administration, Intranasal; Anesthetics, Inhalation; Animals; Animals, Newborn; Apoptosis; Cognitive Dysfunction; Female; Isoflurane; Male; Maze Learning; Rats; Rats, Wistar; Simendan; Vasodilator Agents | 2021 |